U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07395232) titled 'An Efficacy and Safety Study of DFL24498 in the Treatment of AKC' on Dec. 22, 2025.
Brief Summary: This is a phase 3, multicenter, randomized, double-masked, parallel-group, vehicle-controlled study to evaluate the safety and efficacy of DFL24498 compared with vehicle ophthalmic solution, in participants with AKC. Approximately 138 participants who meet all eligibility criteria will be enrolled in the study.
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Atopic Keratoconjunctivitis
Intervention:
DRUG: DFL24498
DFL24498 will be instilled in each eye for 12 Weeks.
DRUG: Vehicle
Vehicle eye drops without...